SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-24-019590
Filing Date
2024-07-01
Accepted
2024-07-01 16:54:40
Documents
1
Period of Report
2024-06-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 7548
  Complete submission text file 0001127602-24-019590.txt   9174
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Issuer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ALKERMES 852 WINTER STREET WALTHAM MA 02451
Business Address
Daglio David Angelo Jr. (Reporting) CIK: 0001837109 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35299 | Film No.: 241091478